Development course of Wuhan aimin pharmaceutical co., ltd.

1969 Wuhan aimin pharmaceutical factory founded by air force radar institute.

1985, sodium aescinate and its preparation were developed and produced in China for the first time.

1986 The worker who produced β -aescinate sodium won the silver award of China Invention Association.

1987β- aescin extraction and preparation technology and surgical clinical application won the third prize of the provincial government for scientific and technological progress.

1988 sodium β -aescinate for injection won the Golden Crane Award for outstanding new products in Hubei Province.

1993 Comrade Ma Quanfa, a medical expert and outstanding entrepreneur, became the director of Wuhan Aimin Pharmaceutical Factory.

1998 sodium aescinate for injection freeze-drying workshop obtained the national standard certificate.

In 2000, Director Ma Quanfa was awarded the title of outstanding young entrepreneur in Wuhan.

In 2000, the freeze-drying workshop obtained the first GMP certificate in Hubei Province.

In 200 1 year, the self-developed Essinker liniment obtained the national new drug certificate and was approved for production and marketing.

In 200 1 and 2002, sodium aescinate for injection won the title of high-quality inspection-free drug in Wuhan.

In 2006, Wuhan Aimin Pharmaceutical Factory was restructured into Wuhan Aimin Pharmaceutical Co., Ltd.

In 2006, Dr. Ankie Lau was awarded the title of model worker by Wuhan Municipal Government.

In 2006, sodium aescinate for injection was listed as the original research variety by the National Development and Reform Commission.

In 2007, the board of directors was reorganized, with Dr. Ankie Lau as the chairman, Dr. Zuo Min as the vice chairman and Professor Ma Quanfa as the general manager.

In 2007, Wuhan Aimin Pharmaceutical Co., Ltd. was recognized as a high-tech enterprise.

In 2007, it became the designated drug-using unit of the 6th National Games.

In 2007, sodium aescinate was approved as "the most independent innovation enterprise case" by the case review committee of enterprise innovation achievements in China.

In 2007, the enterprise was rated as "the most independent innovation enterprise" by China Small and Medium Enterprises Association.